4.5 Review

Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver

期刊

JOURNAL OF HEPATOCELLULAR CARCINOMA
卷 8, 期 -, 页码 1537-1563

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/JHC.S334935

关键词

HCC; tumor-initiating cell; hepatic progenitor; neuroendocrine tumors; hepatoblastoma

类别

资金

  1. Scientific Research Project of Beijing You-an Hospital, CCMU [YNKTTS20180110]
  2. You-an Foundation of Liver Disease and AIDS [YNKTTS20180123]
  3. Beijing Fengtai Health System Research Project [2018-63]

向作者/读者索取更多资源

The primary epithelial tumors of the liver (PETL) exhibit heterogeneous cellular origins, with certain tumors in different categories sharing similar cell origins. Hepatic adenomas, hepatocellular carcinomas, and pure fetal hepatoblastomas share the same cellular origin spectrum, as do bile duct adenomas, peribiliary cysts, and intrahepatic cholangiocellular carcinomas. The cells-of-origin of embryonal HBs include liver stem cells, hepatoblasts, and transitional cells between them.
The primary epithelial tumors of the liver (PETL) are composed of a series of heterogeneous tumors. Although the classification of PETLs has been updated several times by the World Health Organization, the cellular origins of some tumors in this family remain to be precisely depicted. In addition, certain tumors in different categories have similar histology, molecular phenotypes and biological characteristics, suggesting that they may have the same cellular origin. In this work, a narrative review method was adopted to review the relevant papers. By comparing the expression profiles of biomarkers of liver epithelium at different lineages and stages of differentiation, the cells-of-origin of some major members of the PETL family were reassessed. We propose that 1) hepatic adenomas, hepatocellular carcinomas (HCCs) and pure fetal hepatoblastomas (HBs) share the same spectrum in their cellular origin including the hepatocytic-committed progenitors (HCP) and their differentiated descendants. 2) Bile duct adenomas, peribiliary cysts and intrahepatic cholangiocellular carcinomas (ICCs) can share the same spectrum in their cellular origin including the cholangiocytic-committed progenitors (CCP) and their differentiated descendants. 3) The cells-of-origin of embryonal HBs include liver stem cells (LSCs), hepatoblasts, and transitional cells between them. Embryonal HB with small cell element, small cell undifferentiated HB and small cell neuroendocrine carcinoma of the liver can have the same or similar cellsof-origin from LSC. Embryonal HB lacking the small cell component of the LSC phenotype and presenting both hepatocytic and bile duct/ductule components may originate from actual hepatoblasts/hepatic progenitor cells (HPCs) as the combined HCC-ICC does. 4) Teratoid hepatoblastoma and mixed epithelial/mesenchymal HBs can be derived from the LSCs or even less committed extrahepatic pluripotent stem cell. 5) Many members of the PETLs family, including those derived from LSCs, hepatoblasts/HPCs, early HCPs and CCPs, have neuroendocrine potentiality. Except for those primary hepatic neuroendocrine tumor (PHNET) exhibit hepatocytic and/or cholangiocytic phenotypes, other PHNETs subtype may be derived from the descendants of LSC that differentiate towards the upper digestive tract, pancreas or other lineages.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据